0000899243-19-015912.txt : 20190606
0000899243-19-015912.hdr.sgml : 20190606
20190606210238
ACCESSION NUMBER: 0000899243-19-015912
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190604
FILED AS OF DATE: 20190606
DATE AS OF CHANGE: 20190606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kemmerly David L
CENTRAL INDEX KEY: 0001673554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 19884013
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-04
0
0000896262
AMEDISYS INC
AMED
0001673554
Kemmerly David L
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
See Remarks
Common Stock
2019-06-04
4
F
0
1640
113.49
D
20884
D
Common Stock
2019-06-04
4
F
0
410
113.49
D
20474
D
Common Stock
2019-06-04
4
F
0
411
113.49
D
20063
D
Common Stock
2019-06-04
4
F
0
411
113.49
D
19652
D
Common Stock
2019-06-06
4
S
0
4420
113.40
D
15232
D
Common Stock
445
I
Through 401(k) Plan
The total amount of shares beneficially owned includes 219 shares held in an employee stock purchase plan account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.13 to $113.73, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The information in this report is based on a plan statement dated as of March 31, 2019.
General Counsel and Senior Vice President of Government Affairs
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2019-06-06